Tag Archives: abbv

Shire Falls, AbbVie Questioned On Buyout Backtrack

Shares of specialty drugmaker Shire plummeted 23% on the stock market today after word got out late Tuesday that big pharma AbbVie is reconsidering its $55 billion buyout of the company. Shire (SHPG) confirmed the reports Wednesday morning with a statement saying that AbbVie ‘s (ABBV) board intends to “consider whether to withdraw or modify its recommendation in light of the impact of the U.S. Treasury Notice” on Sept. 22. The Treasury Notice is

Infinity Pharma Joins AbbVie On Blood Cancer Drug

Development-stage biotech Infinity Pharmaceuticals (INFI) landed a key deal to develop its blood cancer drug duvelisib in partnership with big pharma AbbVie (ABBV), sending Infinity stock up 46% to a six-month high near 16 on the stock market today. The AbbVie-Infinity collaboration includes an upfront payment of $275 million, and up to $530 million in milestone payments if duvelisib passes successfully through development, approval and launch.

Infinity Pharma JoinsAbbVie On Blood Cancer Drug

Development-stage biotech Infinity Pharmaceuticals (INFI) landed a key deal to develop its blood cancer drug duvelisib in partnership with big pharma AbbVie (ABBV), sending Infinity stock up 46% to a six-month high near 16 on the stock market today. The AbbVie-Infinity collaboration includes an upfront payment of $275 million, and up to $530 million in milestone payments if duvelisib passes successfully through development, approval and launch.